Gene-specific compounds to lead development of anti-cancer drugs

11/28/2004 | Guardian (London), The

Thousands of new drug compounds will be available within the next six years for treating cancer, saving the lives of millions but increasing the National Health Service's drugs outlay, a U.K. newspaper concludes. Many of the new drugs expected to be created by 2010 will be aimed at genetic tumor abnormalities, according to The Observer's investigation.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC